4//SEC Filing
DARGAN CHARLES K 4
Accession 0001437749-20-009466
CIK 0000880242other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 4:38 PM ET
Size
16.6 KB
Accession
0001437749-20-009466
Insider Transaction Report
Form 4
BIOLARGO, INC.BLGO
DARGAN CHARLES K
Chief Financial Officer
Transactions
- Award
Option to purchase common stock
2020-05-01+214,286→ 3,648,286 totalExercise: $0.14From: 2020-08-01Exp: 2030-05-01→ Common stock (214,286 underlying) - Award
Option to purchase common stock
2020-05-01+7,500→ 3,434,000 totalExercise: $0.14From: 2020-05-01Exp: 2030-05-01→ Common stock (7,500 underlying)
Footnotes (4)
- [F1]This Option was granted to Reporting Person to replace an option to purchase 30,000 shares that had been issued approximately 10 years ago to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and current Issuer stock price, pursuant to plan adopted by the Issuer's Compensation Committee.
- [F2]This amount reflects, in addition to the reported option, grant, the expiration on April 30, 2020, of an option to purchase 30,000 shares of common stock.
- [F3]This option vests in four equal installments every three months beginning August 1, 2020.
- [F4]On May 1, 2020, in recognition of recent accomplishments in response to the COVID-19 pandemic, the Issuer's Compensation Committee granted options to the Issuer's employees under the 2018 Equity Incentive Plan, including the option reported herein.
Documents
Issuer
BIOLARGO, INC.
CIK 0000880242
Entity typeother
Related Parties
1- filerCIK 0001112799
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 4:38 PM ET
- Size
- 16.6 KB